BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12200710)

  • 1. Complete remission in hypoplastic acute myeloid leukemia induced by G-CSF without chemotherapy: report on three cases.
    Nimubona S; Grulois I; Bernard M; Drénou B; Godard M; Fauchet R; Lamy T
    Leukemia; 2002 Sep; 16(9):1871-3. PubMed ID: 12200710
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse.
    Choi SJ; Lee JH; Lee JH; Kim S; Seol M; Lee YS; Lee JS; Kim WK; Chi HS; Lee KH
    Leukemia; 2004 Nov; 18(11):1789-97. PubMed ID: 15385924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful hematopoietic reconstitution with granulocyte colony-stimulating factor in a patient with hypoplastic acute myelogenous leukemia.
    Lee M; Chubachi A; Niitsu H; Miura I; Yanagisawa M; Hirokawa M; Miura AB
    Intern Med; 1995 Jul; 34(7):692-4. PubMed ID: 7496088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased numbers of bone marrow blasts in acute myeloid leukaemia patients treated with G-CSF after chemotherapy.
    Kaddar A; Edinger M; Wirth K; Schaefer HE; Lübbert M; Lindemann A
    Br J Haematol; 1997 Aug; 98(2):492-3. PubMed ID: 9266958
    [No Abstract]   [Full Text] [Related]  

  • 6. G-CSF-induced remission in two cases of acute myeloid leukemia.
    Benz R; Goede JS; Parlier V; Mühlematter D; Jotterand M; Fehr J
    Leuk Res; 2008 Jul; 32(7):1148-52. PubMed ID: 18166225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of RAEB-t treated by G-CSF showing complete remission after MST-16 treatment for subsequent reversible leukemia].
    Murate T; Ohashi H; Kagami Y; Hotta T; Murase T; Hirota Y; Kimura K
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2155-8. PubMed ID: 1716093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
    Piccaluga PP; Martinelli G; Malagola M; Rondoni M; Bianchini M; Visani G; Baccarani M
    Haematologica; 2003 Aug; 88(8):ECR28. PubMed ID: 12935987
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete remission in a patient with hypoplastic acute lymphoblastic leukemia induced by granulocyte-colony-stimulating factor.
    Hatta Y; Iwata T; Takeuchi J; Ohshima T; Horie T
    Acta Haematol; 1995; 94(1):39-43. PubMed ID: 7544523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot remission induction therapy with idarubicin, plus an intensified dose of ara-C and priming with granulocyte colony-stimulating factor for acute myeloid leukemia.
    Baek JH; Sohn SK; Kim DH; Kim JG; Yang DH; Kim YK; Lee JJ; Kim HJ
    Acta Haematol; 2007; 117(2):109-14. PubMed ID: 17135724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22).
    Ferrara F; Schiavone EM; Palmieri S; Mele G; Pocali B; Scalia G; Morabito P; Sebastio L; Del Vecchio L
    Hematol J; 2003; 4(3):218-21. PubMed ID: 12764355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
    He XY; Pohlman B; Lichtin A; Rybicki L; Kalaycio M
    Leukemia; 2003 Jun; 17(6):1078-84. PubMed ID: 12764371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial.
    Keating S; Suciu S; de Witte T; Zittoun R; Mandelli F; Belhabri A; Amadori S; Fibbe W; Gallo E; Fillet G; Varet B; Meloni G; Hagemeijer A; Fazi P; Solbu G; Willemze R; ;
    Leukemia; 2003 Jan; 17(1):60-7. PubMed ID: 12529661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
    Vellenga E; van Putten WL; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Jonkhoff AR; Huijgens PC; Verdonck LF; van der Lelie J; Schouten HC; Gmür J; Wijermans P; Gratwohl A; Hess U; Fey MF; Löwenberg B
    Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
    Chen J; Zhou JH; Ball ED
    Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
    Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
    Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells.
    Aglietta M; De Felice L; Stacchini A; Petti MC; Bianchi AC; Aloe Spiriti MA; Sanavio F; Apra F; Piacibello W; Stern AC
    Leukemia; 1991 Nov; 5(11):979-84. PubMed ID: 1961040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases.
    Hanazono Y; Miyazono K; Piao YF; Taketazu F; Chiba S; Miyagawa K; Hirai H; Sakamoto S; Miura Y; Yazaki Y
    Int J Hematol; 1992 Jun; 55(3):243-8. PubMed ID: 1379844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.